{'fraction_non_alphanumeric': 0.025157232704402517, 'fraction_numerical': 0.0, 'mean_word_length': 4.844036697247707, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Reply to Commentary on ‘Prevalence of growth hormone (GH) deficiency in previously GH treated young adults with Prader‐Willi syndrome'

Data sharing is not applicable to this article as no new data were created or analyzed in this study. We would like to thank the authors for their commentary as it gives us the opportunity to repeat our conclusion that adults with PWS should be treated with growth hormone (GH), regardless of GH stimulation test results. Our findings show that conventional testing for adult GHD is not reliable in adults with Prader-Willi syndrome (PWS). This article is protected by copyright. All rights reserved.